Overview

Ancillary Effects of Oral Naloxegol (Movantik)

Status:
Active, not recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether oral Naloxegol can reduce the side effects of opioid painkillers following surgery. This study aims to explore whether Naloxegol can similarly reduce opioid-induced side effects in post-surgical patients. About 130 surgery patients will participate in this study which is being conducted at Cleveland Clinic Main Campus.
Phase:
Phase 4
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Naloxegol